Search Results - "Tieu, Paul"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Comparing Exercise-Induced Musculoskeletal Bleeding in Murine Models of Hemophilia A and B by Tieu, Paul T.M., Chan, Anthony K.C., Gross, Peter L., Matino, Davide

    Published in Blood (23-11-2021)
    “…Background: Hemophilia A and B are recessive X-linked bleeding disorders characterized by the deficiency in coagulation factor VIII and factor IX. Patients…”
    Get full text
    Journal Article
  2. 2

    Von Willebrand Factor Expression in Endothelium in a Co-Culturing System of Acute Lymphoblastic Leukemia by Tieu, Paul T.M., Stevic, Ivan, Matino, Davide, Chan, Anthony K.C.

    Published in Blood (23-11-2021)
    “…Background: Acute lymphoblastic leukemia (ALL) is the most common cause of cancer and death from cancer among children, with an incidence of 1 in 1,750…”
    Get full text
    Journal Article
  3. 3

    Barriers to the hospital treatment among Bede snake charmers in Bangladesh with special reference to venomous snakebite by Yoshimura, Ken, Hossain, Moazzem, Tojo, Bumpei, Tieu, Paul, Trinh, Nathalie Nguyen, Huy, Nguyen Tien, Sato, Miho, Moji, Kazuhiko

    Published in PLoS neglected tropical diseases (02-10-2023)
    “…Snakebite envenoming is a potentially life-threatening global public health issue with Bangladesh having one of the highest rates of snakebite cases. The Bede,…”
    Get full text
    Journal Article
  4. 4

    Molecular Mechanisms of Inhibitor Development in Hemophilia by Tieu, Paul, Chan, Anthony, Matino, Davide

    “…The development of neutralizing antibodies in hemophilia is a serious complication of factor replacement therapy. These antibodies, also known as "inhibitors",…”
    Get full text
    Journal Article
  5. 5

    Anti-Trypanosoma cruzi activity of Coptis rhizome extract and its constituents by Tayama, Yuki, Mizukami, Shusaku, Toume, Kazufumi, Komatsu, Katsuko, Yanagi, Tetsuo, Nara, Takeshi, Tieu, Paul, Huy, Nguyen Tien, Hamano, Shinjiro, Hirayama, Kenji

    Published in Tropical medicine and health (01-03-2023)
    “…Current therapeutic agents, including nifurtimox and benznidazole, are not sufficiently effective in the chronic phase of Trypanosoma cruzi infection and are…”
    Get full text
    Journal Article
  6. 6

    Tolerance to FVIII: Role of the Immune Metabolic Enzymes Indoleamine 2,3 Dyoxigenase-1 and Heme Oxygenase-1 by Matino, Davide, Afraz, Sajjad, Zhao, George, Tieu, Paul, Gargaro, Marco, Fallarino, Francesca, Iorio, Alfonso

    Published in Frontiers in immunology (15-04-2020)
    “…The occurrence of neutralizing anti-FVIII antibodies is a major complication in the treatment of patients affected by hemophilia A. The immune response to…”
    Get full text
    Journal Article
  7. 7

    Bone mineral density in Canadian children with severe haemophilia A or B: a cross-sectional study by Bos, Cecily, Tieu, Paul, Wu, John K, Strike, Karen, Chan, Anthony KC

    Published in Journal of Haemophilia Practice (14-10-2021)
    “…Abstract Background Previous research has shown that bone mineral density (BMD), a measure of bone strength, may be lower among people with haemophilia…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Barriers to the hospital treatment among Bede snake charmers in Bangladesh with special reference to venomous snakebite by Ken Yoshimura, Moazzem Hossain, Bumpei Tojo, Paul Tieu, Nathalie Nguyen Trinh, Nguyen Tien Huy, Miho Sato, Kazuhiko Moji

    Published in PLoS neglected tropical diseases (01-10-2023)
    “…Snakebite envenoming is a potentially life-threatening global public health issue with Bangladesh having one of the highest rates of snakebite cases. The Bede,…”
    Get full text
    Journal Article
  12. 12

    Inferior vena cava syndrome in neonates: An evidence‐based systematic review of the literature by Tieu, Paul, Paes, Bosco, Ahmed, Afrah, Matino, Davide, Chan, Anthony, Bhatt, Mihir

    Published in Pediatric blood & cancer (01-04-2020)
    “…Neonatal inferior vena cava syndrome (IVCS), though uncommon, is associated with significant morbidity and mortality. Information on risk factors, diagnosis,…”
    Get full text
    Journal Article
  13. 13

    MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA: Guest Editor: Giancarlo Costaman by Matino, Davide, Tieu, Paul, Chan, Antony

    “…The development of neutralizing antibodies in hemophilia is a serious complication of factor replacement therapy. These antibodies, also known as “inhibitors”,…”
    Get full text
    Journal Article
  14. 14

    Mini-review on the properties and possible applications of therapeutic oxygen carrier Hemarina-M101 by Varney, Joseph, Rivera, Amanda, Dong, Vinh, Tieu, Paul, Zia, Sairah, Huy, Nguyen Tien

    Published in Transfusion and apheresis science (01-02-2021)
    “…Therapeutic Oxygen Carriers (TOCs) have been studied in the past for utilization in resuscitation fluid, treatment of organ ischemia, and as an alternative to…”
    Get full text
    Journal Article